AANAT | Aralkylamine N-acetyltransferase | | | | |
|
| | Tissue enhanced | 0 |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | | | | |
|
| | Tissue enhanced | 0 |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | | | | |
|
| | Tissue enhanced | 0 |
ABCC12 | ATP-binding cassette, sub-family C (CFTR/MRP), member 12 | | | | | N/A |
| | Tissue enhanced | 0 |
AC003976.2 | TBC1 domain family member 3B | | | | | N/A |
| Vesicles | Tissue enhanced | 0 |
AC136352.7 | | | | | | N/A |
| | Tissue enhanced | 0 |
ACPT | Acid phosphatase, testicular | | | | | |
| | Tissue enhanced | 0 |
ACRC | Acidic repeat containing | | | | |
|
| Vesicles | Tissue enhanced | 0 |
ADORA1 | Adenosine A1 receptor | | | | | |
| Nucleoli | Tissue enhanced | 0 |
ADORA3 | Adenosine A3 receptor | | | | |
|
| | Tissue enhanced | 0 |
AL513478.1 | | | | | | |
| | Tissue enhanced | 0 |
ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | | | | |
|
| | Tissue enhanced | 0 |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | | | | | N/A |
| | Tissue enhanced | 0 |
ALK | Anaplastic lymphoma receptor tyrosine kinase | | | | |
|
| | Tissue enhanced | 0 |
ALMS1 | Alstrom syndrome 1 | | | | |
|
| Nucleus Cytoplasm Centrosome | Tissue enhanced | 0 |
ANKEF1 | Ankyrin repeat and EF-hand domain containing 1 | | | | |
|
| Nucleoli Plasma membrane Cytoplasm | Tissue enhanced | 0 |
ANKRD20A2 | Ankyrin repeat domain 20 family, member A2 | | | | | N/A |
| | Tissue enhanced | 0 |
ANKRD20A4 | Ankyrin repeat domain 20 family, member A4 | | | | | N/A |
| | Tissue enhanced | 0 |
ANKRD30A | Ankyrin repeat domain 30A | | | | |
|
| | Tissue enhanced | 0 |
ANKRD42 | Ankyrin repeat domain 42 | | | | |
|
| Nucleus but not nucleoli Cytoplasm Plasma membrane | Tissue enhanced | 0 |
ANKRD53 | Ankyrin repeat domain 53 | | | | |
|
| | Tissue enhanced | 0 |
ANO2 | Anoctamin 2, calcium activated chloride channel | | | | | N/A |
| Plasma membrane Nucleus but not nucleoli | Tissue enhanced | 0 |
APITD1-CORT | APITD1-CORT readthrough | | | | | |
| | Tissue enhanced | 0 |
AQP5 | Aquaporin 5 | | | | |
|
| | Tissue enhanced | 0 |
ARHGAP28 | Rho GTPase activating protein 28 | | | | |
|
| Nucleus but not nucleoli Cell Junctions | Tissue enhanced | 0 |
ARHGAP39 | Rho GTPase activating protein 39 | | | | | N/A |
| Cytoplasm Nucleus but not nucleoli Cytoskeleton (Microtubules) Cytoskeleton (Cytokinetic bridge) | Tissue enhanced | 0 |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | | | | |
|
| Vesicles | Tissue enhanced | 0 |
ARID3B | AT rich interactive domain 3B (BRIGHT-like) | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
ARL9 | ADP-ribosylation factor-like 9 | | | | |
|
| | Tissue enhanced | 0 |
ARMC2 | Armadillo repeat containing 2 | | | | |
|
| Nucleus | Tissue enhanced | 0 |
ARMS2 | Age-related maculopathy susceptibility 2 | | | | | |
| | Tissue enhanced | 0 |
ART5 | ADP-ribosyltransferase 5 | | | | |
|
| | Tissue enhanced | 0 |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
ASIC3 | Acid-sensing (proton-gated) ion channel 3 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
ASRGL1 | Asparaginase like 1 | | | | |
|
| Cytoskeleton (Microtubules) Nucleus but not nucleoli | Tissue enhanced | 0 |
ATF7IP2 | Activating transcription factor 7 interacting protein 2 | | | | |
|
| Nucleus Nucleoli Cytoplasm | Tissue enhanced | 0 |
AUNIP | Aurora kinase A and ninein interacting protein | | | | |
|
| Centrosome | Tissue enhanced | 0 |
AURKA | Aurora kinase A | | | | |
|
| Nucleus Cytoplasm Centrosome | Tissue enhanced | 0 |
AZIN2 | Antizyme inhibitor 2 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
BEND4 | BEN domain containing 4 | | | | |
|
| Nucleoli Nucleus Cytoplasm | Tissue enhanced | 0 |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | | | | |
|
| Nucleus Nuclear membrane | Tissue enhanced | 0 |
BTBD16 | BTB (POZ) domain containing 16 | | | | | N/A |
| Nucleoli Cytoplasm | Tissue enhanced | 0 |
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
BX649567.1 | | | | | | |
| | Tissue enhanced | 0 |
C10orf111 | Chromosome 10 open reading frame 111 | | | | |
|
| | Tissue enhanced | 0 |
C10orf131 | Chromosome 10 open reading frame 131 | | | | | |
| | Tissue enhanced | 0 |
C10orf25 | Chromosome 10 open reading frame 25 | | | | | |
| | Tissue enhanced | 0 |
C10orf67 | Chromosome 10 open reading frame 67 | | | | |
|
| | Tissue enhanced | 0 |